跳至主要内容
临床试验/ISRCTN56622673
ISRCTN56622673已完成未知

Supporting medicines adherence in bipolar disorder through the use of psychoeducation and Biodose Connect™

Mednet Consult Ltd0 个研究点目标入组 12 人开始时间: 2015年2月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. International Statistical Classification of Diseases and Related Health Problems diagnosis: F31.7 bipolar disorder, currently in remission
  • 2. Taking medication for bipolar disorder
  • 3. Will be treated by Northern Health and Social Care Trust (UK)
  • 4. Medication Adherence Rating Scale score of 6 or less
  • 5. Clinical Global Impression score of 3 or less (mildly ill)
  • 6. Home access to the internet via a laptop or desktop computer
  • 7. Informed consent and registration forms
  • 8. Co-medications and liquid medications can be administered via Biodose Connect™
  • 9. Age 18–64 years old

排除标准

  • 1. Significant cognitive impairment
  • 2. Taking medication that is identified by the Medicines and Healthcare Products Regulatory Agency (UK) as not suitable for blister/biodose packaging
  • 3. Poor communication and/or reading skills

研究者

发起方
Mednet Consult Ltd

相似试验